Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Sofia Ferrer, Michael E. Muratore & Peter Buijnsters. (2022) The intriguing role of USP30 inhibitors as deubiquitinating enzymes from the patent literature since 2013. Expert Opinion on Therapeutic Patents 32:5, pages 523-559.
Read now
Read now
Brian W. Moran, Frankie P. Anderson, Deborah M. Ruth, Ciarán Ó. Fágáin, John P. Dalton & Peter T. M. Kenny. (2010) Fluorobenzoyl dipeptidyl derivatives as inhibitors of the Fasciola hepatica cysteine protease cathepsin L1. Journal of Enzyme Inhibition and Medicinal Chemistry 25:1, pages 1-12.
Read now
Read now
Articles from other publishers (6)
Aaron D. Krabill, Hao Chen, Sajjad Hussain, Chao Feng, Ammara Abdullah, Chittaranjan Das, Uma K. Aryal, Carol Beth Post, Michael K. Wendt, Paul J. Galardy & Daniel P. Flaherty. (2019) Ubiquitin C‐Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine‐Based Inhibitor. ChemBioChem 21:5, pages 712-722.
Crossref
Crossref
Marton Siklos, Manel BenAissa & Gregory R.J. Thatcher. (2015) Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors. Acta Pharmaceutica Sinica B 5:6, pages 506-519.
Crossref
Crossref
G.D. Kishore Kumar, Gustavo E. Chavarria, Amanda K. Charlton-Sevcik, Grace Kim Yoo, Jiangli Song, Tracy E. Strecker, Bronwyn G. Siim, David J. Chaplin, Mary Lynn Trawick & Kevin G. Pinney. (2010) Functionalized benzophenone, thiophene, pyridine, and fluorene thiosemicarbazone derivatives as inhibitors of cathepsin L. Bioorganic & Medicinal Chemistry Letters 20:22, pages 6610-6615.
Crossref
Crossref
Donald J. AbrahamPhilippe G. Nantermet, Evan F. Shalen, Shankar Venkatraman, Hong Zhu & Robert J. Mark. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
447
828
.
Gaetano Leto, Maria Vittoria Sepporta, Marilena Crescimanno, Carla Flandina & Francesca Maria Tumminello. (2010) Cathepsin L in metastatic bone disease: therapeutic implications. Biological Chemistry 391:6.
Crossref
Crossref
G.D. Kishore Kumar, Gustavo E. Chavarria, Amanda K. Charlton-Sevcik, Wara M. Arispe, Matthew T. MacDonough, Tracy E. Strecker, Shen-En Chen, Bronwyn G. Siim, David J. Chaplin, Mary Lynn Trawick & Kevin G. Pinney. (2010) Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors. Bioorganic & Medicinal Chemistry Letters 20:4, pages 1415-1419.
Crossref
Crossref